世界の多嚢胞性卵巣症候群(PCOS)治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV13974)
◆英語タイトル:Global Polycystic Ovary Syndrome (PCOS) Drugs Market Insights and Forecast to 2026
◆商品コード:QYR20NV13974
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは多嚢胞性卵巣症候群(PCOS)治療薬の世界市場について調査・分析した資料です。種類別(経口避妊薬、抗アンドロゲン剤、インスリン感作剤、抗うつ剤、抗肥満剤)の市場規模、用途別(病院、クリニック)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別多嚢胞性卵巣症候群(PCOS)治療薬の競争状況、市場シェア
・世界の多嚢胞性卵巣症候群(PCOS)治療薬市場:種類別市場規模 2015年-2020年(経口避妊薬、抗アンドロゲン剤、インスリン感作剤、抗うつ剤、抗肥満剤)
・世界の多嚢胞性卵巣症候群(PCOS)治療薬市場:種類別市場規模予測 2021年-2026年(経口避妊薬、抗アンドロゲン剤、インスリン感作剤、抗うつ剤、抗肥満剤)
・世界の多嚢胞性卵巣症候群(PCOS)治療薬市場:用途別市場規模 2015年-2020年(病院、クリニック)
・世界の多嚢胞性卵巣症候群(PCOS)治療薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック)
・北米の多嚢胞性卵巣症候群(PCOS)治療薬市場分析:米国、カナダ
・ヨーロッパの多嚢胞性卵巣症候群(PCOS)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの多嚢胞性卵巣症候群(PCOS)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の多嚢胞性卵巣症候群(PCOS)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの多嚢胞性卵巣症候群(PCOS)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited、Addex Therapeutics Ltd.、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co.、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Polycystic Ovary Syndrome (PCOS) Drugs Market
The global Polycystic Ovary Syndrome (PCOS) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Polycystic Ovary Syndrome (PCOS) Drugs Scope and Market Size
Polycystic Ovary Syndrome (PCOS) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polycystic Ovary Syndrome (PCOS) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Polycystic Ovary Syndrome (PCOS) Drugs market is segmented into
Oral Contraceptives
Antiandrogens
Insulin-sensitizing Agent
Antidepressant
Anti-obesity

Segment by Application, the Polycystic Ovary Syndrome (PCOS) Drugs market is segmented into
Hospital
Clinic

Regional and Country-level Analysis
The Polycystic Ovary Syndrome (PCOS) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Polycystic Ovary Syndrome (PCOS) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Polycystic Ovary Syndrome (PCOS) Drugs Market Share Analysis
Polycystic Ovary Syndrome (PCOS) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Polycystic Ovary Syndrome (PCOS) Drugs business, the date to enter into the Polycystic Ovary Syndrome (PCOS) Drugs market, Polycystic Ovary Syndrome (PCOS) Drugs product introduction, recent developments, etc.

The major vendors covered:
Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited
Addex Therapeutics Ltd.
BIOCAD
Merck KGaA
AstraZeneca plc.
Bristol Myers Squibb Co.
Ferring Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.

【レポートの目次】

1 Study Coverage
1.1 Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction
1.2 Market Segments
1.3 Key Polycystic Ovary Syndrome (PCOS) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size Growth Rate by Type
1.4.2 Oral Contraceptives
1.4.3 Antiandrogens
1.4.4 Insulin-sensitizing Agent
1.4.5 Antidepressant
1.4.6 Anti-obesity
1.5 Market by Application
1.5.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue 2015-2026
2.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales 2015-2026
2.2 Global Polycystic Ovary Syndrome (PCOS) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Polycystic Ovary Syndrome (PCOS) Drugs Competitor Landscape by Players
3.1 Polycystic Ovary Syndrome (PCOS) Drugs Sales by Manufacturers
3.1.1 Polycystic Ovary Syndrome (PCOS) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Manufacturers
3.2.1 Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Polycystic Ovary Syndrome (PCOS) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Polycystic Ovary Syndrome (PCOS) Drugs Revenue in 2019
3.2.5 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Polycystic Ovary Syndrome (PCOS) Drugs Price by Manufacturers
3.4 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polycystic Ovary Syndrome (PCOS) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Polycystic Ovary Syndrome (PCOS) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size by Type (2015-2020)
4.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales by Type (2015-2020)
4.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Type (2015-2020)
4.1.3 Polycystic Ovary Syndrome (PCOS) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Polycystic Ovary Syndrome (PCOS) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size by Application (2015-2020)
5.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales by Application (2015-2020)
5.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Application (2015-2020)
5.1.3 Polycystic Ovary Syndrome (PCOS) Drugs Price by Application (2015-2020)
5.2 Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Polycystic Ovary Syndrome (PCOS) Drugs by Country
6.1.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Sales by Country
6.1.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Type
6.3 North America Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs by Country
7.1.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales by Country
7.1.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Type
7.3 Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Polycystic Ovary Syndrome (PCOS) Drugs by Region
8.1.1 Asia Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales by Region
8.1.2 Asia Pacific Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Polycystic Ovary Syndrome (PCOS) Drugs by Country
9.1.1 Latin America Polycystic Ovary Syndrome (PCOS) Drugs Sales by Country
9.1.2 Latin America Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Type
9.3 Central & South America Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs by Country
10.1.1 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales by Country
10.1.2 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.1.5 Sanofi Related Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description and Business Overview
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.2.5 Novartis AG Related Developments
11.3 Teva Pharmaceutical Industries Limited
11.3.1 Teva Pharmaceutical Industries Limited Corporation Information
11.3.2 Teva Pharmaceutical Industries Limited Description and Business Overview
11.3.3 Teva Pharmaceutical Industries Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.3.5 Teva Pharmaceutical Industries Limited Related Developments
11.4 Addex Therapeutics Ltd.
11.4.1 Addex Therapeutics Ltd. Corporation Information
11.4.2 Addex Therapeutics Ltd. Description and Business Overview
11.4.3 Addex Therapeutics Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.4.5 Addex Therapeutics Ltd. Related Developments
11.5 BIOCAD
11.5.1 BIOCAD Corporation Information
11.5.2 BIOCAD Description and Business Overview
11.5.3 BIOCAD Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.5.5 BIOCAD Related Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Corporation Information
11.6.2 Merck KGaA Description and Business Overview
11.6.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.6.5 Merck KGaA Related Developments
11.7 AstraZeneca plc.
11.7.1 AstraZeneca plc. Corporation Information
11.7.2 AstraZeneca plc. Description and Business Overview
11.7.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.7.5 AstraZeneca plc. Related Developments
11.8 Bristol Myers Squibb Co.
11.8.1 Bristol Myers Squibb Co. Corporation Information
11.8.2 Bristol Myers Squibb Co. Description and Business Overview
11.8.3 Bristol Myers Squibb Co. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.8.5 Bristol Myers Squibb Co. Related Developments
11.9 Ferring Pharmaceuticals, Inc.
11.9.1 Ferring Pharmaceuticals, Inc. Corporation Information
11.9.2 Ferring Pharmaceuticals, Inc. Description and Business Overview
11.9.3 Ferring Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.9.5 Ferring Pharmaceuticals, Inc. Related Developments
11.10 Crinetics Pharmaceuticals, Inc.
11.10.1 Crinetics Pharmaceuticals, Inc. Corporation Information
11.10.2 Crinetics Pharmaceuticals, Inc. Description and Business Overview
11.10.3 Crinetics Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.10.5 Crinetics Pharmaceuticals, Inc. Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Products Offered
11.1.5 Sanofi Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Polycystic Ovary Syndrome (PCOS) Drugs Market Estimates and Projections by Region
12.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Polycystic Ovary Syndrome (PCOS) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Polycystic Ovary Syndrome (PCOS) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Polycystic Ovary Syndrome (PCOS) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Polycystic Ovary Syndrome (PCOS) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited、Addex Therapeutics Ltd.、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co.、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の多嚢胞性卵巣症候群(PCOS)治療薬市場2026:インサイト・予測(Global Polycystic Ovary Syndrome (PCOS) Drugs Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。